High Sodium Intake and Fluid Overhydration Predict Cardiac Structural and Functional Impairments in Chronic Kidney Disease

Overview

Journal Front Nutr

Specialty Nutritional Sciences

Date 2024 Jun 11

PMID 38860161

Authors

Suyan Duan

Yuchen Ma

Fang Lu

Chengning Zhang

Honglei Guo

Ming Zeng

Bin Sun

Yanggang Yuan

Changying Xing

Huijuan Mao

Bo Zhang

Affiliations

Soon will be listed here.

Abstract

Background: High sodium intake and fluid overhydration are common factors of and strongly associated with adverse outcomes in chronic kidney disease (CKD) patients. Yet, their effects on cardiac dysfunction remain unclear.

Aims: The study aimed to explore the impact of salt and volume overload on cardiac alterations in non-dialysis CKD.

Methods: In all, 409 patients with CKD stages 1-4 (G1-G4) were enrolled. Daily salt intake (DSI) was estimated by 24-h urinary sodium excretion. Volume status was evaluated by the ratio of extracellular water (ECW) to total body water (TBW) measured by body composition monitor. Recruited patients were categorized into four groups according to DSI (6 g/day) and median ECW/TBW (0.439). Echocardiographic and body composition parameters and clinical indicators were compared. Associations between echocardiographic findings and basic characteristics were performed by Spearman's correlations. Univariate and multivariate binary logistic regression analysis were used to determine the associations between DSI and ECW/TBW in the study groups and the incidence of left ventricular hypertrophy (LVH) and elevated left ventricular filling pressure (ELVFP). In addition, the subgroup effects of DSI and ECW/TBW on cardiac abnormalities were estimated using Cox regression.

Results: Of the enrolled patients with CKD, the median urinary protein was 0.94 (0.28-3.14) g/d and estimated glomerular filtration rate (eGFR) was 92.05 (IQR: 64.52-110.99) mL/min/1.73 m. The distributions of CKD stages G1-G4 in the four groups was significantly different ( = 0.020). Furthermore, compared to group 1 (low DSI and low ECW/TBW), group 4 (high DSI and high ECW/TBW) showed a 2.396-fold (95%CI: 1.171-4.902; = 0.017) excess risk of LVH and/or ELVFP incidence after adjusting for important CKD and cardiovascular disease risk factors. Moreover, combined with eGFR, DSI and ECW/TBW could identify patients with higher cardiac dysfunction risk estimates with an AUC of 0.704 (sensitivity: 75.2%, specificity: 61.0%). The specificity increased to 85.7% in those with nephrotic proteinuria (AUC = 0.713). The magnitude of these associations was consistent across subgroups analyses.

Conclusion: The combination of high DSI (>6 g/d) and high ECW/TBW (>0.439) independently predicted a greater risk of LVH or ELVFP incidence in non-dialysis CKD patients. Moreover, the inclusion of eGFR and proteinuria improved the risk stratification ability of DSI and ECW/TBW in cardiac impairments in CKD.

References

. Essential points from Evidence-based Clinical Practice Guidelines for Chronic Kidney Disease 2018. Clin Exp Nephrol. 2018; 23(1):1-15. PMC: 6344397. DOI: 10.1007/s10157-018-1648-1. View

Hung S, Lai Y, Kuo K, Tarng D . Volume overload and adverse outcomes in chronic kidney disease: clinical observational and animal studies. J Am Heart Assoc. 2015; 4(5). PMC: 4599419. DOI: 10.1161/JAHA.115.001918. View

Fan L, Tighiouart H, Levey A, Beck G, Sarnak M . Urinary sodium excretion and kidney failure in nondiabetic chronic kidney disease. Kidney Int. 2014; 86(3):582-8. PMC: 4149837. DOI: 10.1038/ki.2014.59. View

Campbell K, Johnson D, Bauer J, Hawley C, Isbel N, Stowasser M . A randomized trial of sodium-restriction on kidney function, fluid volume and adipokines in CKD patients. BMC Nephrol. 2014; 15:57. PMC: 3994521. DOI: 10.1186/1471-2369-15-57. View

. Evidence-based practice guideline for the treatment of CKD. Clin Exp Nephrol. 2009; 13(6):537-66. DOI: 10.1007/s10157-009-0237-8. View

Mazarova A, Molnar A, Akbari A, Sood M, Hiremath S, Burns K . The association of urinary sodium excretion and the need for renal replacement therapy in advanced chronic kidney disease: a cohort study. BMC Nephrol. 2016; 17(1):123. PMC: 5011929. DOI: 10.1186/s12882-016-0338-z. View

Heywood J, Fonarow G, Costanzo M, Mathur V, Wigneswaran J, Wynne J . High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. J Card Fail. 2007; 13(6):422-30. DOI: 10.1016/j.cardfail.2007.03.011. View

Olde Engberink R, van den Hoek T, van Noordenne N, van den Born B, Peters-Sengers H, Vogt L . Use of a Single Baseline Versus Multiyear 24-Hour Urine Collection for Estimation of Long-Term Sodium Intake and Associated Cardiovascular and Renal Risk. Circulation. 2017; 136(10):917-926. DOI: 10.1161/CIRCULATIONAHA.117.029028. View

Lambers Heerspink H, Holtkamp F, Parving H, Navis G, Lewis J, Ritz E . Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers. Kidney Int. 2012; 82(3):330-7. DOI: 10.1038/ki.2012.74. View

10.

Cai Q, Lu X, Lu Y, Yee-Moon Wang A . Longitudinal changes of cardiac structure and function in CKD (CASCADE study). J Am Soc Nephrol. 2014; 25(7):1599-608. PMC: 4073437. DOI: 10.1681/ASN.2013080899. View

11.

McDonagh T, Metra M, Adamo M, Gardner R, Baumbach A, Bohm M . Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With.... Eur Heart J. 2021; 42(48):4901. DOI: 10.1093/eurheartj/ehab670. View

12.

Hwang J, Chin H, Kim S, Kim D, Kim S, Park J . Effects of intensive low-salt diet education on albuminuria among nondiabetic patients with hypertension treated with olmesartan: a single-blinded randomized, controlled trial. Clin J Am Soc Nephrol. 2014; 9(12):2059-69. PMC: 4255393. DOI: 10.2215/CJN.01310214. View

13.

. Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of, Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2016; 17(4):412. DOI: 10.1093/ehjci/jew041. View

14.

Frohlich E . The salt conundrum: a hypothesis. Hypertension. 2007; 50(1):161-6. DOI: 10.1161/HYPERTENSIONAHA.107.088328. View

15.

Ogawa T, Nitta K . Clinical Impact of Left Ventricular Diastolic Dysfunction in Chronic Kidney Disease. Contrib Nephrol. 2018; 195:81-91. DOI: 10.1159/000486938. View

16.

DElia L, Rossi G, Schiano di Cola M, Savino I, Galletti F, Strazzullo P . Meta-Analysis of the Effect of Dietary Sodium Restriction with or without Concomitant Renin-Angiotensin-Aldosterone System-Inhibiting Treatment on Albuminuria. Clin J Am Soc Nephrol. 2015; 10(9):1542-52. PMC: 4559518. DOI: 10.2215/CJN.09110914. View

17.

Tsai Y, Chiu Y, Tsai J, Kuo H, Hung C, Hwang S . Association of fluid overload with cardiovascular morbidity and all-cause mortality in stages 4 and 5 CKD. Clin J Am Soc Nephrol. 2014; 10(1):39-46. PMC: 4284411. DOI: 10.2215/CJN.03610414. View

18.

Playford D, Strange G, Celermajer D, Evans G, Scalia G, Stewart S . Diastolic dysfunction and mortality in 436 360 men and women: the National Echo Database Australia (NEDA). Eur Heart J Cardiovasc Imaging. 2020; 22(5):505-515. PMC: 8081414. DOI: 10.1093/ehjci/jeaa253. View

19.

Kim E, Choi M, Lee J, Oh J, Seo J, Lee Y . Extracellular Fluid/Intracellular Fluid Volume Ratio as a Novel Risk Indicator for All-Cause Mortality and Cardiovascular Disease in Hemodialysis Patients. PLoS One. 2017; 12(1):e0170272. PMC: 5242490. DOI: 10.1371/journal.pone.0170272. View

20.

Stopic B, Medic-Brkic B, Savic-Vujovic K, Davidovic Z, Todorovic J, Dimkovic N . Biomarkers and Predictors of Adverse Cardiovascular Events in Different Stages of Chronic Kidney Disease. Dose Response. 2022; 20(3):15593258221127568. PMC: 9478703. DOI: 10.1177/15593258221127568. View